Bud Fig 1
Budesonide Inhalant
Product Images NDC 0487-9701
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0487-9701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nephron Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bud Fig 3
Chemical Structure (Budesonide 01)
Figure 1 (Budesonide 02)
The text describes the mean change from baseline in nighttime asthma symptoms over a period of 12 weeks for a placebo group and two other treatment groups receiving different doses.*
Principal Display Panel (0.25 mg / 2 mL Ampule Carton)
This is a prescription medication in a 2mL unit-dose ampule used for inhalation only. It contains 0.25mg of micronized budesonide, which should be used immediately after opening in jet nebulizers only. The medication should be stored at 20°- 25°C (68°-77°F) and protected from light in a foil envelope placed upright in the carton. Instructions for use should be followed as directed by a physician. For further details, check the package insert or call customer service.*
Principal Display Panel (0.5 mg / 2 mL Ampule Carton)
Budesonide 11
Budesonide 12
Budesonide 13
This is a prescription medication with the NDC code 0487-9701-01. It is for inhalation only and comes in a plastic ampule with a 2 mL sterile suspension that contains 0.5 mg of micronized budesonide. The inactives include citric acid, edetate disodium dihydrate, polysorbate 80, sodium chloride, sodium citrate, and water for injection. The medication should be used as directed by a physician and the package insert should be reviewed for full prescribing information. Once opened, the contents of an ampule should be used immediately. It should be used only in a jet nebulizer and not in an ultrasonic nebulizer. The medication should be stored at controlled room temperature between 20-25°C (68-77°F) and should be protected from light. The medication is manufactured by a company called "Finetherapeutics" located in West Columbia, SC. The product should be kept out of reach of children.*
Budesonide 14
Budesonide 15
Budesonide 16
Ifu 04 2020 Update
This text provides instructions for handling and using Budesonide inhalation suspension. The medication should be stored at room temperature and shaking the ampule before use is recommended. The medication is used with a nebulizer machine and the user should wear an appropriate mask to avoid getting mist in their eyes. Finally, the used ampule should be disposed of properly.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
